Dermatologic Toxicities Associated with Tebentafusp for Uveal Melanoma: A Review of Clinical Trials and Real-World Evidence
Simple Summary Tebentafusp is a novel therapy and the first treatment shown to improve survival in patients with advanced uveal melanoma. Because it directs the immune system against a protein that is also found on normal pigment-producing cells in the skin, skin-related side effects are common, particularly rash and i...